270 related articles for article (PubMed ID: 11857336)
1. Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris.
Tsunoda K; Ota T; Suzuki H; Ohyama M; Nagai T; Nishikawa T; Amagai M; Koyasu S
Eur J Immunol; 2002 Mar; 32(3):627-33. PubMed ID: 11857336
[TBL] [Abstract][Full Text] [Related]
2. A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice.
Aoki-Ota M; Tsunoda K; Ota T; Iwasaki T; Koyasu S; Amagai M; Nishikawa T
Br J Dermatol; 2004 Aug; 151(2):346-54. PubMed ID: 15327541
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.
Eming R; Hennerici T; Bäcklund J; Feliciani C; Visconti KC; Willenborg S; Wohde J; Holmdahl R; Sønderstrup G; Hertl M
J Immunol; 2014 Nov; 193(9):4391-9. PubMed ID: 25252957
[TBL] [Abstract][Full Text] [Related]
4. Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus vulgaris.
Anzai H; Fujii Y; Nishifuji K; Aoki-Ota M; Ota T; Amagai M; Nishikawa T
J Dermatol Sci; 2004 Aug; 35(2):133-42. PubMed ID: 15265525
[TBL] [Abstract][Full Text] [Related]
5. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3.
Tsunoda K; Ota T; Aoki M; Yamada T; Nagai T; Nakagawa T; Koyasu S; Nishikawa T; Amagai M
J Immunol; 2003 Feb; 170(4):2170-8. PubMed ID: 12574390
[TBL] [Abstract][Full Text] [Related]
6. Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus.
Amagai M; Tsunoda K; Suzuki H; Nishifuji K; Koyasu S; Nishikawa T
J Clin Invest; 2000 Mar; 105(5):625-31. PubMed ID: 10712434
[TBL] [Abstract][Full Text] [Related]
7. Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris.
Yokoyama T; Matsuda S; Takae Y; Wada N; Nishikawa T; Amagai M; Koyasu S
Int Immunol; 2011 Jun; 23(6):365-73. PubMed ID: 21525154
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
[TBL] [Abstract][Full Text] [Related]
9. A single helper T cell clone is sufficient to commit polyclonal naive B cells to produce pathogenic IgG in experimental pemphigus vulgaris.
Takahashi H; Kuwana M; Amagai M
J Immunol; 2009 Feb; 182(3):1740-5. PubMed ID: 19155523
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris.
Shimizu A; Ishiko A; Ota T; Tsunoda K; Koyasu S; Amagai M; Nishikawa T
Arch Dermatol Res; 2002 Oct; 294(7):318-23. PubMed ID: 12373337
[TBL] [Abstract][Full Text] [Related]
11. Aire-dependent thymic expression of desmoglein 3, the autoantigen in pemphigus vulgaris, and its role in T-cell tolerance.
Wada N; Nishifuji K; Yamada T; Kudoh J; Shimizu N; Matsumoto M; Peltonen L; Nagafuchi S; Amagai M
J Invest Dermatol; 2011 Feb; 131(2):410-7. PubMed ID: 21048786
[TBL] [Abstract][Full Text] [Related]
12. Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice.
Hofrichter M; Dworschak J; Emtenani S; Langenhan J; Weiß F; Komorowski L; Zillikens D; Stöcker W; Probst C; Schmidt E; Goletz S
Front Immunol; 2018; 9():1935. PubMed ID: 30233569
[TBL] [Abstract][Full Text] [Related]
13. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
[TBL] [Abstract][Full Text] [Related]
14. A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes.
Aoyama Y; Owada MK; Kitajima Y
Eur J Immunol; 1999 Jul; 29(7):2233-40. PubMed ID: 10427986
[TBL] [Abstract][Full Text] [Related]
15. Synergistic pathogenic effects of combined mouse monoclonal anti-desmoglein 3 IgG antibodies on pemphigus vulgaris blister formation.
Kawasaki H; Tsunoda K; Hata T; Ishii K; Yamada T; Amagai M
J Invest Dermatol; 2006 Dec; 126(12):2621-30. PubMed ID: 16841036
[TBL] [Abstract][Full Text] [Related]
16. Tolerance induction by the blockade of CD40/CD154 interaction in pemphigus vulgaris mouse model.
Aoki-Ota M; Kinoshita M; Ota T; Tsunoda K; Iwasaki T; Tanaka S; Koyasu S; Nishikawa T; Amagai M
J Invest Dermatol; 2006 Jan; 126(1):105-13. PubMed ID: 16417225
[TBL] [Abstract][Full Text] [Related]
17. Transgenic rescue of desmoglein 3 null mice with desmoglein 1 to develop a syngeneic mouse model for pemphigus vulgaris.
Hata T; Nishifuji K; Shimoda K; Sasaki T; Yamada T; Nishikawa T; Koyasu S; Amagai M
J Dermatol Sci; 2011 Jul; 63(1):33-9. PubMed ID: 21602032
[TBL] [Abstract][Full Text] [Related]
18. Confirmation of a disease model of pemphigus vulgaris: characterization and correlation between disease parameters in 90 mice.
Holm TL; Markholst H
Exp Dermatol; 2010 Aug; 19(8):e158-65. PubMed ID: 20201956
[TBL] [Abstract][Full Text] [Related]
19. Pemphigus vulgaris and its active disease mouse model.
Amagai M
Curr Dir Autoimmun; 2008; 10():167-81. PubMed ID: 18460885
[TBL] [Abstract][Full Text] [Related]
20. Low pathogenicity of anti-desmoglein 3 immunoglobulin G autoantibodies contributes to the atypical clinical phenotypes in pemphigus.
Saleh MA; Hashimoto R; Kase Y; Amagai M; Yamagami J
J Dermatol; 2015 Jul; 42(7):685-9. PubMed ID: 25914046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]